- Home
- LYEL vs DKL Comparison
LYEL vs DKL Comparison
Compare LYEL & DKL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LYEL
- DKL
- Stock Information
- Founded
- LYEL 2018
- DKL 2012
- Country
- LYEL United States
- DKL United States
- Employees
- LYEL N/A
- DKL N/A
- Industry
- LYEL Biotechnology: Pharmaceutical Preparations
- DKL Natural Gas Distribution
- Sector
- LYEL Health Care
- DKL Energy
- Exchange
- LYEL Nasdaq
- DKL Nasdaq
- Market Cap
- LYEL 207.7M
- DKL 2.3B
- IPO Year
- LYEL 2021
- DKL N/A
- Fundamental
- Price
- LYEL $8.87
- DKL $42.85
- Analyst Decision
- LYEL Sell
- DKL Buy
- Analyst Count
- LYEL 2
- DKL 4
- Target Price
- LYEL $15.00
- DKL $44.25
- AVG Volume (30 Days)
- LYEL 332.0K
- DKL 128.3K
- Earning Date
- LYEL 08-06-2025
- DKL 08-05-2025
- Dividend Yield
- LYEL N/A
- DKL 10.35%
- EPS Growth
- LYEL N/A
- DKL 7.97
- EPS
- LYEL N/A
- DKL 2.98
- Revenue
- LYEL $65,000.00
- DKL $938,491,000.00
- Revenue This Year
- LYEL N/A
- DKL $21.19
- Revenue Next Year
- LYEL N/A
- DKL N/A
- P/E Ratio
- LYEL N/A
- DKL $14.39
- Revenue Growth
- LYEL N/A
- DKL N/A
- 52 Week Low
- LYEL $7.65
- DKL $34.59
- 52 Week High
- LYEL $38.40
- DKL $45.71
- Technical
- Relative Strength Index (RSI)
- LYEL 46.43
- DKL 55.35
- Support Level
- LYEL $8.52
- DKL $42.44
- Resistance Level
- LYEL $9.80
- DKL $43.97
- Average True Range (ATR)
- LYEL 1.22
- DKL 0.83
- MACD
- LYEL -0.17
- DKL -0.15
- Stochastic Oscillator
- LYEL 8.84
- DKL 38.79
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.
About DKL Delek Logistics Partners L.P. Common Units representing Limited Partner Interests
Delek Logistics Partners LP owns and operates logistics and marketing assets for crude oil and intermediate and refined products. The company's segment includes gathering and processing; wholesale marketing and terminalling; storage and transportation and investment in pipeline joint ventures. It generates maximum revenue from the wholesale marketing and terminalling segment, which provides marketing services for the refined products output of the Delek Holdings' refineries, engages in wholesale activity at its terminals and terminals owned by third parties, whereby it purchases light product for sale and exchange to third parties, and provides terminalling services at its refined products terminals to independent third parties and Delek Holdings.